Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone‐specific complex

The AML/CBFA family of runt homology domain (rhd) transcription factors regulates expression of mammalian genes of the hematopoietic lineage. AML1, AML2, and AML3 are the three AML genes identified to date which influence myeloid cell growth and differentiation. Recently, AML‐related proteins were identified in an osteoblast‐specific promoter binding complex that functionally modulates bone‐restricted transcription of the osteocalcin gene. In the present study we demonstrate that in primary rat osteoblasts AML‐3 is the AML family member present in the osteoblast‐specific complex. Antibody specific for AML‐3 completely supershifts this complex, in contrast to antibodies with specificity for AML‐1 or AML‐2. AML‐3 is present as a single 5.4 kb transcript in bone tissues. To establish the functional involvement of AML factors in osteoblast differentiation, we pursued antisense strategies to alter expression of rhd genes. Treatment of osteoblast cultures with rhd antisense oligonucleotides significantly decreased three parameters which are linked to differentiation of normal diploid osteoblasts: the representation of alkaline phosphatase–positive cells, osteocalcin production, and the formation of mineralized nodules. Our findings indicate that AML‐3 is a key transcription factor in bone cells and that the activity of rhd proteins is required for completion of osteoblast differentiation. J. Cell. Biochem. 66:1–8, 1997. © 1997 Wiley‐Liss, Inc.

[1]  G. Stein,et al.  Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. , 1996, Endocrinology.

[2]  N. Lenny,et al.  AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. , 1996, Oncogene.

[3]  G. Stein,et al.  An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Stein,et al.  Bone tissue‐specific transcription of the osteocalcin gene: Role of an activator osteoblast‐specific complex and suppressor hox proteins that bind the OC box , 1996, Journal of cellular biochemistry.

[5]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[7]  G. Karsenty,et al.  A PEBP2/AML-1-related Factor Increases Osteocalcin Promoter Activity through Its Binding to an Osteoblast-specific cis-Acting Element (*) , 1995, The Journal of Biological Chemistry.

[8]  G. Stein,et al.  The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. , 1995, Biochemistry.

[9]  J. Rowley,et al.  AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. , 1995, Blood.

[10]  A. Simeone,et al.  Expression of runt in the mouse embryo , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  N. Lenny,et al.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation , 1995, Molecular and cellular biology.

[12]  G. Stein,et al.  Proximal promoter binding protein contributes to developmental, tissue‐restricted expression of the rat osteocalcin gene , 1995, Journal of cellular biochemistry.

[13]  N. Speck,et al.  A new transcription factor family associated with human leukemias. , 1995, Critical reviews in eukaryotic gene expression.

[14]  S. Hiebert,et al.  Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. , 1995, Critical reviews in eukaryotic gene expression.

[15]  G. Stein,et al.  Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Yamaguchi-Iwai,et al.  Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Rodan,et al.  Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. , 1994, Molecular endocrinology.

[18]  I. Bar-Am,et al.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. , 1994, Genomics.

[19]  M. Ohki Molecular basis of the t(8;21) translocation in acute myeloid leukaemia. , 1993, Seminars in cancer biology.

[20]  M. Ohki,et al.  The Runt domain identifies a new family of heteromeric transcriptional regulators. , 1993, Trends in genetics : TIG.

[21]  Y. Ito,et al.  PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Nevins,et al.  Role of E2F transcription factor in E1A-mediated trans activation of cellular genes , 1991, Journal of virology.

[23]  G. Stein,et al.  Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix , 1990, Journal of cellular physiology.

[24]  S. Rodan,et al.  Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. , 1980, Endocrinology.